DBV Technologies SA (DBVT)
9.57
-0.23
(-2.35%)
USD |
NASDAQ |
Oct 12, 16:00
9.57
0.00 (0.00%)
After-Hours: 16:15
DBV Technologies Free Cash Flow (Quarterly) : -49.68M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -49.68M |
| December 31, 2025 | -35.57M |
| September 30, 2025 | -32.48M |
| June 30, 2025 | -34.45M |
| March 31, 2025 | -19.68M |
| December 31, 2024 | -12.13M |
| September 30, 2024 | -22.85M |
| June 30, 2024 | -35.80M |
| March 31, 2024 | -36.03M |
| December 31, 2023 | -14.04M |
| September 30, 2023 | -19.62M |
| Date | Value |
|---|---|
| June 30, 2023 | -25.72M |
| March 31, 2023 | -20.95M |
| December 31, 2022 | -23.90M |
| September 30, 2022 | -20.42M |
| June 30, 2022 | -10.49M |
| March 31, 2022 | -1.614M |
| December 31, 2021 | -15.35M |
| September 30, 2021 | -22.94M |
| June 30, 2021 | -30.13M |
| March 31, 2021 | -36.39M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Cellectis SA | -14.59M |
| Akari Therapeutics Plc | -3.112M |
| EDAP TMS SA | -4.949M |
| Bicycle Therapeutics Plc | -49.96M |
| Autolus Therapeutics Plc | -26.08M |